Anette Løken Eilertsen

The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis

Anette Løken Eilertsen, Else Høibraaten, Ingrid Os et al. · Maturitas · 2005 · 60 citations

Inflammation, Thrombosis, Thrombopoiesis +12

Mechanisms of thrombosis related to hormone therapy

Per Morten Sandset, Else Høibraaten, Anette Løken Eilertsen et al. · Thrombosis Research · 2009 · 55 citations

Thrombopoiesis, Thrombosis, Blood Platelet +8

Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis

Anette Løken Eilertsen, Leiv Sandvik, Marie Christine Mowinckel et al. · Thrombosis Research · 2006 · 33 citations

Thrombosis, Differential Effects, Medicine +8

Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation

Anette Løken Eilertsen, Elisabeth Qvigstad, Trine Opstad Andersen et al. · Maturitas · 2006 · 31 citations · Full text

Thrombosis, Blood Platelet, Medicine +11

Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers

Anette Løken Eilertsen, Leiv Sandvik, B. STEINSVIK et al. · Journal of Thrombosis and Haemostasis · 2008 · 29 citations · Full text

Inflammation, Rheumatology, Differential Impact +14